Vaclav Kirsner, PhD

Current

• Founder at bioPecus Corporation
• Founder CEO at bioZhena Corporation

Past

• Founder and President at Conception Technology Inc. (CTI)

Education

• City University
• Colorado State University
• University of Southampton

• Univerzita Karlova v Praze

see less...

1 more...

Recommended

1 person has recommended Vaclav

Connections

500+ connections

Industry

Medical Devices

Vaclav Kirsner, PhD’s Summary

Our vision is to make it possible for every pregnancy to be deliberate and to impact women’s healthcare with highly desirable user-centric electronic diagnostic tools. Our unique opportunity is to do this in a manner free of chemicals, and free of religious, ethical and political controversy.

bioZhena is a medical device & informatics company focused on female reproductive health: conception aid, birth control aid, ovulation, screening for cancer and other conditions. A prototype has received FDA 510k certification.

bioZhena is attractive for the right investor. For 1 or 2 early investors I might agree to pay back the invested cash via profit sharing. The main reason why we are attractive is that our technology is superior to that developed by Unipath (Unilever), sold for $150 M to Inverness. Another comparable sold for $450 M (Adeza Biomedical); another: FEI Women's Health sold to Barr for $280 M only 3 years after start up.

What we have: A new diagnostic modality for reproductive medicine uses a sensor that records, interprets (with a display in plain language, e.g., FERTILE DAY 1), and stores data charting reproductive cycles in terms of a previously unexplored but well-understood biological process.

No other technology:

(i) tracks in vivo said fundamental process that causes menstrual cycles and much else in women's health;
(ii) is available for birth control;
(iii) performs an automatic, unseen and worry-free, screen for cervical cancer;
(iv) provides electronically shareable data for the medical profession, a new type patient profiling;
(v) provides an elegant tool for end-organ effects monitoring to both the pharma R&D and to any physician (re: individualization of therapy).


About bioPecus Corp. (currently dormant):

Our objective method of tracking progress toward ovulation is essential for efficient livestock breeding. No other tech can do it - they do not track said fundamental biological process, and do not detect ovulation.

Vaclav Kirsner, PhD’s Specialties:

We are actually a re-start. We continue to seek certain management candidates. CIO. Medical Director. Legal, financial expertise. One more independent director. We do have an excellent Medical Advisory Board.

Some details of this nature are in documents accessible via the Applications to people directly connected with me. Such introductory details can also be accessed via my Google profile - link elsewhere in this profile.

Specialty: Innovation all around incl. in capital formation.

Vaclav Kirsner, PhD’s Experience

• Founder

  bioPecus Corporation

  (Veterinary industry)

  December 2007 — Present (2 years )

  Agribusiness application of the smart biosensor intellectual property that is shared with bioZhena Corporation.

• Founder CEO

  bioZhena Corporation

  (Medical Devices industry)

  January 2006 — Present (3 years 11 months)

  The inventor and developer of tissue-biosensing of folliculogenesis in vivo, and a longtime biomedical entrepreneur. There was another period of privately funded R&D before I founded bioZhena, and not without expenditures including blood, sweat and tears... which was not much different from the CTI experience. The innovation in female reproductive medicine results from interdisciplinary approach and synergy of a number of disciplines: electrochemistry, physical chemistry, analytical chemistry, physiology, biochemistry, endocrinology, and computing and electronics. Having discovered follicular waves before they became generally understood, the instrumentation enabled the small clinical studies by Benedetto of University of Turin First Gynecology Clinic, by Fehring of the Marquette University Natural Family Planning Clinic, and by Fehring & Schlaff of the University of Colorado Health Sciences Center, studies not supervised by us in order to assure objectivity.

• Founder and President

  Conception Technology Inc. (CTI)

  (Medical Devices industry)

  January 1991 — October 1996 (5 years 10 months)

  I started CTI with my own funds. Prior to this, I was for a decade a senior research scientist at the pharma firm Wellcome Foundation Ltd. (Glaxo-Wellcome) in pharmaceutical bio-electrochemistry; and before that a research fellow (investigating electro-acupuncture) at the City University of London. After the 5 bootstrapping years at CTI, I realized that I was the inventor of tissue-biosensing of folliculogenesis in vivo; earlier, we simply had a superior technique of predicting and detecting ovulation. My many private placement subscribers (mostly women) could see the superiority in the performance data. But CTI was taken over by new investor-imposed management, I resigned, and CTI closed shop. Finally I was able to focus - after the years of chasing penny stock investors - on the intellectual property.

Vaclav Kirsner, PhD’s Education

• City University

  Research Fellow , Bio-Electrochemistry and Mechanism of Electro-acupuncture

  This fellowship was the time of my transition from fundamental to applied science, and a preparatory step towards the subsequent long and enjoyable exploratory pharmaceutical research tenure at Wellcome, where my slogan was "Life is electrochemistry", meaning "all life processes are electrochemical in nature" --- it is all about charge transfers. (Some call it bio-electricity...)

• Colorado State University

  Postdoctoral Fellow , Physical Chemistry - Electrochemistry

  This was a stint in online computing in the Rockies after the off-line computerisation of my doctoral work at sea level! DEC PDP after the British ICL bureau computing experience.

• University of Southampton

  Ph.D. , Physical Chemistry - Electrochemistry

  The U of So'ton (just re-organized from a former college of London U) being one of the two strongest British schools of electrochemistry, I prided myself on being the first postgraduate at Southampton to computerize an electrochemical experiment... (Truth to be told, I did not care for the thermodynamic focus of my supervisor Prof - and don't start me on the subject of how Nernst's thermodynamic authority in the 19th century caused us driving int' comb' engines in the 20th, by suppressing the kinetic approach to phys chem-electrochem! Why, we should be running fuel cells!!)

• Univerzita Karlova v Praze

  M.S. , Chemistry and Physics

  My interest in biocybernetics notwithstanding (the rigid Czech educational system of the time did not allow for it [and how did we envy the American flexibility!]), I did a thesis project on some fundamentals of the hydrogen electrode. Prague had a recent Nobel for electrochemistry, and a medical friend who used it to study some medical problem had advised that for medical research a study of the science was a better approach than a study of medicine per se. Towards project completion, I corresponded with renowned experts in said field, and ended up getting an invitation from Prof Ives in London...

Additional Information

Vaclav Kirsner, PhD’s Interests:

Interested in high caliber people who have what it takes to contribute to this medical technology venture development. Secretly wishing for the occasional polyhistor, and not so secretly for additional female participants in the enterprise. After all, we are pioneering eukairosic diagnostic tools for women and their health professionals. I can be reached by phone at 970-484-1272 (especially if arranged via email). As noted on the last line in the Specialties section, innovation and unorthodox originality is inherent in bioZhena (and will be also in the separate venture under the bioPecus plan, a separate additional wealth generator). No bull from anyone will be tolerated. Either you can grasp what we have and are about, or we just waste some more time talking. Web 2.0 being inherent in b. plan goes without saying. We are not propagating old ways.

Vaclav Kirsner, PhD’s Groups:

•    Life Sciences Industry Executive Network
•    FundingUniverse.com Angel Investor & VC Network
•    Business Angels' Tabernacle
•    CEO Club
•    Venture Capital Syndicate
•    Private Equity and Venture Capital Group
•    Healthcare Technology Alliance
•    Biopreneur
•    Health Informatics Technology (HIT)
•    Venture Capital Cafe (+5000 Members)
•    Enopoly Mergers & Acquisitions Networking Group
•    Hedge Fund Group (HFG)
•    Family Offices Group
•    Private Equity Investment Group
•    Venture Capital Private Equity Roundtable
•    Venture Capital
•    Golden Capital Network
•    Global Private Equity & Venture Capital
•    Private Equity Networking
•    CXO (CEO, COO, CKO, CFO, CMO, CAO, CVO, CDO, CRO, CLO, CSO & CTO) Community
•    Capital Booster
•    Angel Investor Group
•    Accredited Investor Report
•    New York Venture Community
•    Healthcare M&A Advisors
•    Southern California Venture Capital Community
•    The Life Science Executive Exchange
•    SuperInvestor LIG
•    Medical Devices Entrepreneurs, CEO's and MD's
•    Medical Devices Group
•    Silicon Valley Venture Community
•    Medical Device Guru
•    CEO/ CIO/COE/COO/CFO/Head/VP/ Director/President Level - Senior Leadership Group
•    Fabless Global - ASIC/FPGA/IP (3000+ members)
•    Venture Capital Group
•    Medical Devices & IVD's
•    Healthcare & Life Sciences
•    Medical Device Opportunity
•    Medical Device Inventors
•    Life Science Venture Capital
•    Biotech Investment Group
•    Deal Flow Network™
•    Accredited Investors Network
•    Healthcare Investment Professionals
•    Investment Placement
•    Entrepreneur 2.0 (maxiwill.com)
•    Life Science Business Club
•    Life Science Consultants
•    Deal Flow Source
•    UCITS for Hedge Funds
•    Deal Flow Source: Biotech, Pharma & Healthcare

Vaclav Kirsner, PhD’s Honors:

Actually, successful implementation of the bioZhena (and separately bioPecus) business plan is the only honor or achievement I respect and aim at. If you are curious about the etymology of those names, then you may be compatible.

Vaclav Kirsner, PhD’s Contact Settings

Interested In:

• consulting offers
• new ventures
• job inquiries
• expertise requests
• business deals
• getting back in touch